Seven Eight Capital’s Loxo Oncology, Inc LOXO Stock Holding History

Seven Eight Capital’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-9,700	Closed	-$894K	–	633
2017 Q3	$894K	Buy	+9,700	New	+$754K	0.11%	269

Other funds holding LOXO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Seven Eight Capital's LOXO Position: Q4 2017 in Review

Seven Eight Capital sold out of Loxo Oncology, Inc (LOXO) in Q4 2017, closing a stake of 9,700 shares — an estimated $894K sold.

Seven Eight Capital first reported a position in LOXO in Q3 2017 and held it in 1 quarter. The position peaked at $894K in Q3 2017. 141 funds tracked by Wall St. Rank hold LOXO as of Q4 2017.

Seven Eight Capital reported no remaining Loxo Oncology, Inc position as of Q4 2017 after selling out during the quarter.
Seven Eight Capital sold 9,700 Loxo Oncology, Inc shares in Q4 2017, an estimated $894K.
Seven Eight Capital first reported a position in Loxo Oncology, Inc in Q3 2017 and held it in 1 quarter.
Seven Eight Capital's Loxo Oncology, Inc position peaked at $894K in Q3 2017.
141 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2017.

Based on Seven Eight Capital's 13F filing for Q4 2017, filed 12 Feb 2018.